1_img1424895986.jpg 2_img1424896008.jpg 3_img1424896028.jpg 4_img1424896053.jpg
ГЛЕДФАРМ ЛТД intro pharmacovigilance logo-img
  • 1-img1423128723_img1424877095.jpg
  • 2-img1423128732_img1424877082.jpg
  • 3-img1423128813_img1424877070.jpg
  • 4-img1423128825_img1424877057.jpg
  • analiz111_img1422534233.jpg

ALBELA tablet

ALBENDAZOLE

Intestinal forms of helminth infestation and cutaneous Larva Migrans (short-term treatment with low doses): enterobiasis, ankylostomiasis and necatoriasis, hymenolepiasis, teniasis, strongyloidosis, ascariasis, trichocephaliasis, clonorchiasis, opisthorchiasis, cutaneous Larva Migrans, lambliasis in children.

Systemic helminth infections (long-term treatment with high doses):

cystic echinococcosis (caused by Echinococcus granulosus):

  • when surgery is impossible;

  • before surgery;

  • after surgery, if presurgical treatment was short, if dissemination of helminths is observed, or living forms have been found during the surgery;

  • after percutaneous drainage of cysts for diagnostic or therapeutic purposes;

alveolar echinococcosis (caused by Echinococcus multiocularis):

  • when the disease is inoperable, particularly in case of local or distant metastases;

  • after palliative surgery;

  • after radical surgery or liver transplantation;

neurocysticercosis (caused by larvae of Taenia solium):

  • in presence of isolated or multiple cysts or granulomatous brain lesion;

  • in case of arachnoidal or intraventricular cysts;

  • in racemous cysts;

capillariasis (caused by Capillaria philippinensis), gnathostomosis (caused by Gnathostoma spinigerum and related species), trichinellosis (caused by Trichinella spiralis and T.pseudospiralis), toxocariasis (caused by Toxocara canis and related species).

1 tablet contains albendazole 400 mg;

View instructions Dounload instruction
All Preparations